Ceritinib for ALK-Rearrangement-Positive Non-Small Cell Lung Cancer.

ABSTRACT:

SUBMITTER: Nix NM 

PROVIDER: S-EPMC4601895 | biostudies-literature | 2015 Mar-Apr

REPOSITORIES: biostudies-literature